Add to ORKGThe Author(s) 2015. This article is published with open access at Springerlink.com Introduction: Evolution of antibacterial resistance in pathogenic enterococcal strains poses a growing therapeutic challenge. Daptomycin, a cyclic lipopeptide, exhibits broad antibiotic activity against Gram-positiv
Context: Daptomycin is the only antibiotic available with in vitro bactericidal activity against van...
Daptomycin is the first antibiotic in a new class of cyclic lipopeptides, active in vitro against Gr...
ABSTRACT Treatment of multidrug-resistant enterococci has become a challenging clinical problem in h...
Daptomycin is a cyclic lipopeptide antibiotic used for the treatment of Gram-positive infections inc...
Vancomycin-resistant enterococci (VRE) are important nosocomial pathogens. Invasive VRE infections a...
The Author(s) 2015. This article is published with open access at Springerlink.com Introduction: The...
International audienceVancomycin-resistant enterococci (VRE) are important nosocomial pathogens. Inv...
ABSTRACTIn the face of increasing resistance to currently available antibiotics, there is a continue...
Background: Increasing antimicrobial resistance among bacterial pathogens has prompted attempts to d...
Infections caused by drug-resistant pathogens are on the rise. Daptomycin, a cyclic lipopeptide with...
We report a case series of 11 patients with severe E. faecium infections treated with daptomycin. Al...
The emergence of multidrug-resistant enterococci as a leading cause of hospital-acquired infection i...
Daptomycin is a cyclic lipopeptide approved by the European Medicines Agency (EMEA) for the treatmen...
Daptomycin is a novel cyclic lipopeptide antibiotic that provides rapid bactericidal activity agains...
Armando Gonzalez-Ruiz,1 R Andrew Seaton,2 Kamal Hamed3 1Darent Valley Hospital, Dartford, UK; 2Queen...
Context: Daptomycin is the only antibiotic available with in vitro bactericidal activity against van...
Daptomycin is the first antibiotic in a new class of cyclic lipopeptides, active in vitro against Gr...
ABSTRACT Treatment of multidrug-resistant enterococci has become a challenging clinical problem in h...
Daptomycin is a cyclic lipopeptide antibiotic used for the treatment of Gram-positive infections inc...
Vancomycin-resistant enterococci (VRE) are important nosocomial pathogens. Invasive VRE infections a...
The Author(s) 2015. This article is published with open access at Springerlink.com Introduction: The...
International audienceVancomycin-resistant enterococci (VRE) are important nosocomial pathogens. Inv...
ABSTRACTIn the face of increasing resistance to currently available antibiotics, there is a continue...
Background: Increasing antimicrobial resistance among bacterial pathogens has prompted attempts to d...
Infections caused by drug-resistant pathogens are on the rise. Daptomycin, a cyclic lipopeptide with...
We report a case series of 11 patients with severe E. faecium infections treated with daptomycin. Al...
The emergence of multidrug-resistant enterococci as a leading cause of hospital-acquired infection i...
Daptomycin is a cyclic lipopeptide approved by the European Medicines Agency (EMEA) for the treatmen...
Daptomycin is a novel cyclic lipopeptide antibiotic that provides rapid bactericidal activity agains...
Armando Gonzalez-Ruiz,1 R Andrew Seaton,2 Kamal Hamed3 1Darent Valley Hospital, Dartford, UK; 2Queen...
Context: Daptomycin is the only antibiotic available with in vitro bactericidal activity against van...
Daptomycin is the first antibiotic in a new class of cyclic lipopeptides, active in vitro against Gr...
ABSTRACT Treatment of multidrug-resistant enterococci has become a challenging clinical problem in h...